Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study-Reference-Cited by-同舟云学术

Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study

Published:2013-10-31 Issue:1 Volume:13 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Baffert Sandrine,Cottu Paul,Kirova Youlia M,Mercier Florence,Simondi Cécile,Bachelot Thomas,Le Rhun Emilie,Levy Christelle,Gutierrez Maya,Madranges Nicolas,Moldovan Cristian,Coudert Bruno,Spaëth Dominique,Serin Daniel,Cotté François-Emery,Benjamin Laure,Maillard Cathie,Laulhere-Vigneau Sabine,Durand-Zaleski Isabelle

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/article/10.1186/1472-6963-13-456/fulltext.html

Reference29 articles.

1. Dabakuyo TS, Bonnetain F, Roignot P, Poillot ML, Chaplain G, Altwegg T, Hedelin G, Arveux P: Population-based study of breast cancer survival in Cote d’Or (France): prognostic factors and relative survival. Ann Oncol. 2008, 19 (2): 276-283. 10.1093/annonc/mdm491.

2. Biswas G, Bhagwat R, Khurana R, Menon H, Prasad N, Parikh PM: Brain metastasis–evidence based management. J Cancer Res Ther. 2006, 2 (1): 5-13. 10.4103/0973-1482.19768.

3. Lin NU, Winer EP: Brain metastases: the HER2 paradigm. Clin Cancer Res. 2007, 13 (6): 1648-1655. 10.1158/1078-0432.CCR-06-2478.

4. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R: Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006, 107 (4): 696-704. 10.1002/cncr.22041.

5. Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, et al: Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res. 2011, 17 (14): 4834-4843. 10.1158/1078-0432.CCR-10-2962.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Economic Burden of Malignant Brain Tumors;Advances in Experimental Medicine and Biology;2023

2. Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases;Journal of Managed Care & Specialty Pharmacy;2022-06

3. Stereotactic radiosurgery in the treatment of adults with metastatic brain tumors;Journal of Neurosurgical Sciences;2020-06

4. Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France;The Breast;2016-12

5. ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study;Journal of Oncology Practice;2016-02